JOHN FEENEY: Open Payments
NPI 1528049475 · MURRIETA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$701 in 31 payments from 14 companies in 2025. Trend: 2023 $69 · 2024 $544 · 2025 $701
Food & beverage: $701
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $183 |
| ABBVIE INC. | 4 | $88 |
| GlaxoSmithKline, LLC. | 3 | $85 |
| Collegium Pharmaceutical, Inc. | 3 | $62 |
| Verity Pharmaceuticals Inc. | 2 | $49 |
| Lilly USA, LLC | 2 | $36 |
| Exact Sciences Corporation | 2 | $34 |
| Boston Scientific Corporation | 1 | $33 |
| Inspire Medical Systems, Inc. | 1 | $31 |
| Aimmune Therapeutics, Inc. | 1 | $26 |
Products named: AIRSUPRA, VRAYLAR, BREZTRI, Belbuca, Tlando, Cologuard Collection Kit, WaveWriter Alpha Prime 16, SHINGRIX.
Industry payments across CA — which companies pay providers there.
